Close
Help




JOURNAL

Retrovirology: Research and Treatment

Mapping of Receptor Binding Interactions with the FIV Surface Glycoprotein (SU); Implications Regarding Immune Surveillance and Cellular Targets of Infection

Submit a Paper


Retrovirology: Research and Treatment 2012:4 1-11

Original Research

Published on 11 Jul 2012

DOI: 10.4137/RRT.S9429


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Retrovirology: Research and Treatment

Abstract

Similar to HIV, FIV uses a two-receptor mechanism to infect CD4+ T cells, the primary target cells in the cat. The T cell activation marker, CD134, serves as a primary binding receptor similar to the role of CD4 for HIV and facilitates interaction with the entry receptor, CXCR4. Heparan sulfate proteoglycans (HSPG) can also act as binding receptors for certain tissue culture adapted FIV and HIV isolates. In the present study, we employed site-directed mutagenesis to investigate the importance of specific residues on the FIV envelope for CD134 and HSPG interactions. We show that certain mutations that disrupt CD134 interactions facilitate HSPG binding by FIV-PPR. In particular, an E407K mutation at the base of the V3 loop knocks out CD134 binding; enhances HSPG binding; and in combination with additional Env mutations E656K and V817I increases entry into CD134-, CXCR4+ target cells by greater than 80-fold over wild type FIV-PPR. The CD134-independent mutant, termed FIV-PPRcr, exhibits a broadened host cell range, but also becomes readily susceptible to CD134-dependent neutralizing monoclonal antibodies. The findings are consistent with the notion that FIV-PPRcr Env has an “open” conformation that readily associates with CXCR4 directly, similar to wild type FIV-PPR Env after CD134 binding. The findings highlight the utility of a two-receptor mechanism that allows FIV V3 residues critical for CXCR4 binding to remain cryptic until reaction occurs with the primary binding receptor, thus thwarting immune surveillance.



Downloads

PDF  (3.10 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Retrovirology: Research and Treatment
It is an honor to publish in Libertas Academia journals, I strongly recommend researchers to submit their articles.  The entire submission, review and publication process for our article in Retrovirology: Research and Treatment was clear and easy.  The staff explained everything and helped me whenever I asked, they were supportive and very polite.  Comments from reviewers were professional and very helpful in improving the quality of the manuscript. Publication fees were reasonable and fair.  As ...
Dr Mqondisi Tshabalala (University of Zimbabwe, Avondale Harare, Zimbabwe)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube